Does ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Cause Extra dose administered? 216 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 216 reports of Extra dose administered have been filed in association with ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. This represents 2.0% of all adverse event reports for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT.
216
Reports of Extra dose administered with ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
2.0%
of all ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT reports
2
Deaths
43
Hospitalizations
How Dangerous Is Extra dose administered From ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT?
Of the 216 reports, 2 (0.9%) resulted in death, 43 (19.9%) required hospitalization, and 3 (1.4%) were considered life-threatening.
Is Extra dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT. However, 216 reports have been filed with the FAERS database.
What Other Side Effects Does ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Cause?
Haemarthrosis (3,360)
Haemorrhage (2,925)
Fall (709)
Arthralgia (561)
Muscle haemorrhage (554)
Limb injury (525)
Drug ineffective (513)
Joint injury (511)
Contusion (496)
Pain (484)
What Other Drugs Cause Extra dose administered?
TIRZEPATIDE (6,774)
DULAGLUTIDE (3,047)
LORATADINE (1,556)
DUPILUMAB (1,422)
FEXOFENADINE (1,413)
NAPROXEN (908)
POLYETHYLENE GLYCOL 3350 (589)
ACETAMINOPHEN (552)
DALFAMPRIDINE (519)
FLUTICASONE\SALMETEROL (499)
Which ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Alternatives Have Lower Extra dose administered Risk?
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs APALUTAMIDE
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT vs APATINIB